
Iopromide is an active pharmaceutical ingredient (API) used as an X-ray and CT scan contrast agent for medical imaging.
The global Iopromide API market was valued at US$ 139 million in 2023 and is anticipated to reach US$ 181.3 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The market for Iopromide API is driven by the need for precise and accurate medical imaging in diagnostic procedures. Iopromide enhances the visibility of blood vessels and tissues, aiding in the diagnosis of various medical conditions. The demand for high-quality and reliable contrast agents contributes to the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Iopromide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iopromide API.
Report Scope
The Iopromide API market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Iopromide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Iopromide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Stellite
Haichang Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Production by Region
North America
Europe
China
Japan
South Korea
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Iopromide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Iopromide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Iopromide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Iopromide API Market Overview
1.1 Product Definition
1.2 Iopromide API Segment by Type
1.2.1 Global Iopromide API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Iopromide API Segment by Application
1.3.1 Global Iopromide API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Market Growth Prospects
1.4.1 Global Iopromide API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Iopromide API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Iopromide API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Iopromide API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Iopromide API Production Market Share by Manufacturers (2019-2024)
2.2 Global Iopromide API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Iopromide API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Iopromide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Iopromide API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Iopromide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Iopromide API, Product Offered and Application
2.8 Global Key Manufacturers of Iopromide API, Date of Enter into This Industry
2.9 Iopromide API Market Competitive Situation and Trends
2.9.1 Iopromide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Iopromide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Iopromide API Production by Region
3.1 Global Iopromide API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Iopromide API Production Value by Region (2019-2030)
3.2.1 Global Iopromide API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Iopromide API by Region (2025-2030)
3.3 Global Iopromide API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Iopromide API Production by Region (2019-2030)
3.4.1 Global Iopromide API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Iopromide API by Region (2025-2030)
3.5 Global Iopromide API Market Price Analysis by Region (2019-2024)
3.6 Global Iopromide API Production and Value, Year-over-Year Growth
3.6.1 North America Iopromide API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Iopromide API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Iopromide API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Iopromide API Production Value Estimates and Forecasts (2019-2030)
3.6.5 South Korea Iopromide API Production Value Estimates and Forecasts (2019-2030)
3.6.6 India Iopromide API Production Value Estimates and Forecasts (2019-2030)
4 Iopromide API Consumption by Region
4.1 Global Iopromide API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Iopromide API Consumption by Region (2019-2030)
4.2.1 Global Iopromide API Consumption by Region (2019-2024)
4.2.2 Global Iopromide API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Iopromide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Iopromide API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Iopromide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Iopromide API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Iopromide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Iopromide API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Iopromide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Iopromide API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Iopromide API Production by Type (2019-2030)
5.1.1 Global Iopromide API Production by Type (2019-2024)
5.1.2 Global Iopromide API Production by Type (2025-2030)
5.1.3 Global Iopromide API Production Market Share by Type (2019-2030)
5.2 Global Iopromide API Production Value by Type (2019-2030)
5.2.1 Global Iopromide API Production Value by Type (2019-2024)
5.2.2 Global Iopromide API Production Value by Type (2025-2030)
5.2.3 Global Iopromide API Production Value Market Share by Type (2019-2030)
5.3 Global Iopromide API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Iopromide API Production by Application (2019-2030)
6.1.1 Global Iopromide API Production by Application (2019-2024)
6.1.2 Global Iopromide API Production by Application (2025-2030)
6.1.3 Global Iopromide API Production Market Share by Application (2019-2030)
6.2 Global Iopromide API Production Value by Application (2019-2030)
6.2.1 Global Iopromide API Production Value by Application (2019-2024)
6.2.2 Global Iopromide API Production Value by Application (2025-2030)
6.2.3 Global Iopromide API Production Value Market Share by Application (2019-2030)
6.3 Global Iopromide API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Bayer
7.1.1 Bayer Iopromide API Corporation Information
7.1.2 Bayer Iopromide API Product Portfolio
7.1.3 Bayer Iopromide API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Bayer Main Business and Markets Served
7.1.5 Bayer Recent Developments/Updates
7.2 Stellite
7.2.1 Stellite Iopromide API Corporation Information
7.2.2 Stellite Iopromide API Product Portfolio
7.2.3 Stellite Iopromide API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Stellite Main Business and Markets Served
7.2.5 Stellite Recent Developments/Updates
7.3 Haichang Pharmaceutical
7.3.1 Haichang Pharmaceutical Iopromide API Corporation Information
7.3.2 Haichang Pharmaceutical Iopromide API Product Portfolio
7.3.3 Haichang Pharmaceutical Iopromide API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Haichang Pharmaceutical Main Business and Markets Served
7.3.5 Haichang Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Iopromide API Industry Chain Analysis
8.2 Iopromide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Iopromide API Production Mode & Process
8.4 Iopromide API Sales and Marketing
8.4.1 Iopromide API Sales Channels
8.4.2 Iopromide API Distributors
8.5 Iopromide API Customers
9 Iopromide API Market Dynamics
9.1 Iopromide API Industry Trends
9.2 Iopromide API Market Drivers
9.3 Iopromide API Market Challenges
9.4 Iopromide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Bayer
Stellite
Haichang Pharmaceutical
Ìý
Ìý
*If Applicable.
